Cargando…

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

BACKGROUND AND HYPOTHESIS: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, yet a significant proportion of individuals on clozapine continue to experience disabling symptoms, despite being treated with an adequate dose. There is a need for adjunct treatments to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neill, Erica, Rossell, Susan L, Yolland, Caitlin, Meyer, Denny, Galletly, Cherrie, Harris, Anthony, Siskind, Dan, Berk, Michael, Bozaoglu, Kiymet, Dark, Frances, Dean, Olivia M, Francis, Paul S, Liu, Dennis, Phillipou, Andrea, Sarris, Jerome, Castle, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673271/ https://www.ncbi.nlm.nih.gov/pubmed/35857752 http://dx.doi.org/10.1093/schbul/sbac065

Ejemplares similares

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
por: Rossell, Susan L., et al.
Publicado: (2016)

M99. INVESTIGATING THE BEST PREDICTIVE CLINICAL FEATURES OF ANTI-N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS IN THE 2010 AUSTRALIAN NATIONAL SURVEY OF HIGH IMPACT PSYCHOSIS (SHIP) COHORT
por: Rossell, Susan, et al.
Publicado: (2020)

N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial
por: McKetin, Rebecca, et al.
Publicado: (2021)

The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
por: Raghu, Ganesh, et al.
Publicado: (2021)

N-Acetylcysteine (NAC): Impacts on Human Health
por: Tenório, Micaely Cristina dos Santos, et al.
Publicado: (2021)

N-acetylcysteine (NAC) and in psychodermatological conditions. Is it useful?
por: Jimenez, A., et al.
Publicado: (2023)

F69. MUSCARINIC M1 RECEPTOR SEQUENCE VARIATION AND GENERAL COGNITION
por: Carruthers, Sean, et al.
Publicado: (2018)

T61. ANTISACCADE AND MEMORY GUIDED SACCADE PERFORMANCE ACROSS THE SCHIZOPHRENIA CONTINUUM
por: Thomas, Elizabeth, et al.
Publicado: (2018)

T249. THE ROYAL AUSTRALIAN AND NEW ZEALAND CLINICAL PRACTICE GUIDELINES FOR SCHIZOPHRENIA AND RELATED DISORDERS (2016) – A STEP TOWARDS BETTER CARE?
por: Galletly, Cherrie, et al.
Publicado: (2018)

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

F83. INVESTIGATING THE RELATIONSHIP BETWEEN NEGATIVE SYMPTOM PROFILE AND COGNITIVE FUNCTION IN SCHIZOPHRENIA
por: Yolland, Caitlin, et al.
Publicado: (2018)

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

NAC, NAC, Knockin’ on Heaven's door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells
por: Kalyanaraman, Balaraman
Publicado: (2022)

N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
por: Bavarsad Shahripour, Reza, et al.
Publicado: (2014)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
por: Baetas, João, et al.
Publicado: (2019)

N-acetylcysteine (NAC) decreases binge eating in a rodent model
por: Hurley, Matthew M., et al.
Publicado: (2016)

Are personality disturbances in anorexia nervosa related to emotion processing or eating disorder symptomatology?
por: Phillipou, Andrea, et al.
Publicado: (2015)

Visual training program for body dysmorphic disorder: protocol for a novel intervention pilot and feasibility trial
por: Beilharz, Francesca, et al.
Publicado: (2018)

Repositioning N-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application
por: Mahumane, Gillian D., et al.
Publicado: (2020)

T85. LIVING WITH PSYCHOSIS IN LATER LIFE
por: Galletly, Cherrie, et al.
Publicado: (2020)

Non-visual hallucinations in Parkinson’s disease: a systematic review
por: Toh, Wei Lin, et al.
Publicado: (2023)

Use of Oral N-Acetylcysteine (NAC) in Non-Acetaminophen-Induced Acute Hepatic Failure
por: Sharieff, Saleem, et al.
Publicado: (2023)

An Overlooked Brain Region in the Aetiology of Anorexia Nervosa: The Importance of Behaviourally Driven Neuroimaging Analysis
por: Phillipou, Andrea, et al.
Publicado: (2018)

Mental health status of individuals with a mood-disorder during the COVID-19 pandemic in Australia: Initial results from the COLLATE project
por: Van Rheenen, Tamsyn E., et al.
Publicado: (2020)

Considerations for assessing the impact of the COVID-19 pandemic on mental health in Australia
por: Tan, Eric J, et al.
Publicado: (2020)

Mental health status of healthcare versus other essential workers in Australia amidst the COVID-19 pandemic: Initial results from the collate project
por: Toh, Wei Lin, et al.
Publicado: (2021)

An overview of current mental health in the general population of Australia during the COVID-19 pandemic: Results from the COLLATE project
por: Rossell, Susan L, et al.
Publicado: (2021)

Chemical Changes in Nonthermal Plasma-Treated N-Acetylcysteine (NAC) Solution and Their Contribution to Bacterial Inactivation
por: Ercan, Utku K., et al.
Publicado: (2016)

Efficacy of a two bag acetylcysteine regimen to treat paracetamol overdose (2NAC study)
por: Wong, Anselm, et al.
Publicado: (2020)

N-acetylcysteine (NAC) attenuates quorum sensing regulated phenotypes in Pseudomonas aeruginosa PAO1
por: Lima, Emília Maria França, et al.
Publicado: (2023)

The neuropsychiatric effects of vitamin C deficiency: a systematic review
por: Plevin, David, et al.
Publicado: (2020)

Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies
por: Arnautovska, Urska, et al.
Publicado: (2022)

Mental health of individuals with and without eating disorders across six months and two waves of COVID-19
por: Phillipou, Andrea, et al.
Publicado: (2021)

Elevated Chemerin Levels in Pakistani Men: An Interrelation with Metabolic Syndrome Phenotypes
por: Fatima, Syeda Sadia, et al.
Publicado: (2013)

Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study
por: Balzan, Ryan P., et al.
Publicado: (2015)

N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review
por: Guerini, Marta, et al.
Publicado: (2022)

Investigating predictors contributing to the expression of schizotypy during the COVID-19 pandemic
por: Toh, Wei Lin, et al.
Publicado: (2022)

Surviving the COVID-19 pandemic: An examination of adaptive coping strategies
por: Meyer, Denny, et al.
Publicado: (2022)

Self-reported and behavioural impulsivity in anorexia nervosa
por: Phillipou, Andrea, et al.
Publicado: (2016)

Effects of semaglutide on body weight in clozapine-treated people with schizophrenia and obesity: study protocol for a placebo-controlled, randomised multicentre trial (COaST)
por: Siskind, Dan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hnfks9vfjfer33pb3a4kj5d200